Načítá se...
Harnessing the immune response to target tumors
Development of “immune-based targeted therapy” in oncology has limited experience with signal pathway modulation. However, as we have become better versed in understanding immune function related to anticancer response, “hints” of specific targets associated with sensitivity and resistance have been...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000Research
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461900/ https://ncbi.nlm.nih.gov/pubmed/28620466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.10795.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|